Hilton Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.43M Buy
20,019
+8,160
+69% +$2M 0.33% 69
2025
Q4
$3.01M Buy
11,859
+1,171
+11% +$294K 0.23% 100
2025
Q3
$2.64M Buy
10,688
+565
+6% +$135K 0.21% 92
2025
Q2
$2.43M Buy
10,123
+964
+11% +$224K 0.19% 96
2025
Q1
$2.08M Buy
9,159
+2,272
+33% +$500K 0.18% 94
2024
Q4
$1.42M Buy
6,887
+297
+5% +$65.2K 0.12% 114
2024
Q3
$1.6M Buy
+6,590
New +$1.54M 0.12% 107
2024
Q2
Sell
-6,779
Closed -$1.52M 179
2024
Q1
$1.52M Buy
6,779
+3,817
+129% +$861K 0.14% 109
2023
Q4
$651K Buy
+2,962
New +$626K 0.07% 104

Other funds holding STE

Hilton Capital Management's STE Position: Q1 2026 in Review

Hilton Capital Management increased its Steris (STE) stake by 69% in Q1 2026, buying an estimated $2M and bringing the position to 20,019 shares worth $4.43M. The position accounts for 0.33% of the portfolio, ranked #69.

Hilton Capital Management first reported a position in STE in Q4 2023 and has held it in 9 quarters since. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Hilton Capital Management held 20,019 shares of Steris worth $4.43M as of Q1 2026.
  • Hilton Capital Management bought 8,160 Steris shares in Q1 2026, an estimated $2M.
  • Steris made up 0.33% of Hilton Capital Management's portfolio in Q1 2026, its #69 holding.
  • Hilton Capital Management first reported a position in Steris in Q4 2023 and has held it in 9 quarters since.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.